Scorpiops walteri sp. n. (Scorpiones: Scorpiopidae) from Myanmar

Posted by
  Scorpiops walteri sp. n. (Scorpiones: Scorpiopidae) from Myanmar Abstract A new species Scorpiops walteri sp . n . (Scorpiopidae) is described from Myanmar, fully illustrated with color photos showing its morphology and habitus. Scorpiops walteri sp . n . is the only species of the genus with a combination of the following five characters: chelal trichobothrium Eb 3 located in middle of manus between trichobothria Dt and Est ; patella of pedipalp with 11–12 ventral and 19 external trichobothria; fingers of pedipalps strongly undulate in male; pedipalp movable finger with ca. 47 IAD; and chela length to width ratio 2.8 in male. Kovařík, F. 2026 . Scorpiops walteri sp. n. (Scorpiones: Scorpiopidae) from Myanmar. Euscorpius , No. 437: 1-13.  https://mds.marshall.edu/euscorpius/vol2026/iss437/1/

Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab’)2 and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic Area

Posted by

 


Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab’)2 and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic Area

Study objectives

North American pit viper antivenoms, CroFab® and ANAVIP®, contain galactose--1,3-galactose (α-GAL) oligosaccharide. We compared adverse drug reactions, including presumed anaphylaxis, following administration of these antivenoms and investigated biological plausibility of these antivenoms leading to anaphylaxis in α-GAL-immunoglobulin (Ig) E-sensitized individuals.

Methods

We performed 2 studies. A retrospective chart review from the Arkansas Poison Center (May 2021 to July 2023) identified adverse drug reactions and presumed anaphylaxis in patients treated with crotaline antivenom. Two allergists (JK, LM), blinded to the antivenom used, adjudicated presumed anaphylaxis cases. To assess whether antivenoms could activate basophils from α-GAL-IgE-sensitized individuals, basophil activation tests were performed on blood from 5 α-GAL-IgE-sensitized participants with a history of mammalian meat allergy. Basophil activation was assessed by %CD63 upregulation.

Results

Adverse drug reactions without presumed anaphylaxis occurred in 7 out of 171 (4.1%) Fab recipients versus 8 out of 37 (21.6%) F(ab’)2 recipients (Δ=17.5%, 95% confidence interval [CI] [4.0 to 31.0]). Presumed anaphylaxis was observed in 3 out of 171 (1.8%) for Fab and 6/37 (16.2%) for F(ab’)2 (Δ=14.3%, 95% CI 2.5 to 26.2). In the basophil activation tests, the mean EC50 for basophil CD63 activation was 144-fold higher for Fab (mean, [standard deviation]; 647 μg/mL of antivenom [627]) compared to F(ab’)2 (4.48 μg/mL of antivenom [2.75]).

Conclusion

We demonstrate a substantial incidence of adverse drug reactions and presumed anaphylaxis to crotaline antivenoms in an α-GAL endemic region, with F(ab’)2 antivenom associated with more reactions than F(ab). Clinicians in α-GAL endemic regions should be cautious in the use of antivenoms, especially for patients with α-GAL allergy.

Filip, A. B., Mahmood, L., Tilly, C., Foster, H. R., Jackson, F., Banner, W., Platts-Mills, T. A., Wilson, J., Bortz, P. S., Charlton, N., & Kennedy, J. L. (2026). Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab’)2 and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic Area. Annals of Emergency Medicine, 87(3), 292-302. https://doi.org/10.1016/j.annemergmed.2025.06.618